Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marika Attili
Institution:
Bambino Gesù Children's Hospital
Observed institutions:
Università Cattolica del Sacro Cuore,
Bambino Gesù Children's Hospital,
National Research Council,
Institute of Cell Biology and Neurobiology
ORCID:
0000-0003-1409-6253
Observed ORCID:
0000-0003-1409-6253
OpenAlex ID:
A5116478506
Targeting the MDM2 ‐ MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer
2025
·
Sonia Valentini
, Giada Mele
, et al.
·
Molecular Oncology
·
9
PDF
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3–FOXO1 rhabdomyosarcoma
2025
·
Francesca Antonella Aiello
, Lucrezia D’Archivio
, et al.
·
Cell Death Discovery
·
5
PDF
Exploring the heterodimer MDM2/MDM4 interaction region uncovers high-affinity peptides for therapeutic p53-reactivation
2025
·
Marika Attili
, Sonia Valentini
, et al.
·
Frontiers in Chemical Biology
·
3
PDF
From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment
2026
·
Elisa Macrì
, Marika Attili
, et al.
·
Frontiers in Cell and Developmental Biology
PDF
Abstract B015: CDK12 pharmacological targeting promotes cell death by abrogating DNA damage response, impairs PAX3-FOXO1 expression and synergizes with BRD4 and PARP inhibitors in fusion positive rhabdomyosarcoma
2025
·
Marika Attili
, Lucrezia D'Archivio
, et al.
·
Cancer Research
Author response for "Targeting the MDM2 ‐ MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer"
2024
·
Sonia Valentini
, Giada Mele
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
6
Citation count:
17
H-index:
3
I10-index:
Year
Topic
Type